Aequus Pharmaceuticals Inc.

DB:AEQ Stock Report

Market Cap: €455.6k

Aequus Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AEQ?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders19,838,96615%
General Public112,795,46585%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 3 shareholders own 14.96% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.46%
Douglas Janzen
12,553,800€43.1k0%no data
5.21%
Marc Lustig
6,916,666€23.8k0%no data
0.28%
Ann Fehr
368,500€1.3k0%no data